Core Insights - The company is focused on expanding its proprietary low nicotine technology to help adult smokers reduce nicotine consumption and improve health outcomes [2][15] - A strategic pivot towards higher-margin branded products and partnerships with retail chains is underway, aiming to enhance market presence and consumer awareness [3][4] Financial Performance - For Q4 2025, net revenues decreased to $3.5 million from $4.0 million, a decline of 12% [7][11] - Gross profit improved to a loss of $0.8 million, compared to a loss of $1.1 million in the previous quarter, reflecting a 33.5% improvement [7][11] - Operating loss decreased to $2.8 million from $3.2 million, a reduction of 31.5% [7][11] - The company ended 2025 with cash of $7.1 million and no outstanding debt, indicating a strengthened financial position [4][7] Product and Market Expansion - The company has expanded its VLN product availability to 48 states and increased retail distribution, with a focus on enhancing consumer awareness [7][12] - New product formats and partnerships are being developed to diversify the reduced nicotine content product category [3][12] - The introduction of new natural style cigarette products is expected to accelerate revenue and margin growth [12] Operational Highlights - The company eliminated over $8 million of legacy debt during 2025, improving its balance sheet and cost structure [4] - A $9.5 million non-dilutive settlement related to an insurance claim from a facility fire in 2022 has been secured, aiding in the transition to growth [4] - The company is actively engaging with FDA regulators and public health stakeholders to support its harm reduction initiatives [4]

Core Insights - 22nd Century Group, Inc. is experiencing early sales momentum for its VLN low nicotine cigarette products in the U.S. market, with plans to expand to over 5,000 retail outlets by 2026 as consumer interest grows [1][5][8] Group 1: Product and Technology - The company's proprietary low nicotine technology aims to help adult smokers reduce nicotine consumption, providing an alternative to highly addictive products like vapes [2] - VLN low nicotine combustible cigarettes are the only FDA-authorized cigarettes designed to help reduce nicotine consumption, with a nicotine content of 95% less than traditional cigarettes [10][13] - The technology is based on non-GMO reduced nicotine tobacco plants developed through patented methods, ensuring commercial scalability [12] Group 2: Regulatory Environment - The U.S. FDA proposed a rule in January 2025 to mandate a maximum nicotine level of 0.7 milligrams per gram in combustible cigarettes, positioning VLN favorably in this evolving regulatory landscape [3] - The WHO Framework Convention on Tobacco Control supports nicotine reduction as a strategy for reducing tobacco dependence, aligning with the company's mission [4] Group 3: Market Opportunity and Sales Traction - In Q4 2025, approximately 8,800 cartons of VLN cigarettes were distributed across about 1,700 new retail outlets, indicating strong early consumer adoption [5] - The company is expanding its distribution strategy by securing placements with large convenience store retailers and wholesalers to increase visibility and access [7] - Early adoption of VLN products validates the company's belief that there is a significant underserved market of adult smokers seeking alternatives [6][8] Group 4: Future Outlook - The company anticipates sustained smoker adoption of VLN products and plans to grow its retail footprint significantly in the coming years [8] - There is growing international interest in the company's proprietary low nicotine tobacco leaf, indicating potential for global expansion [8][9]

Core Insights - 22nd Century Group, Inc. ended 2025 with $7.1 million in cash and is debt-free, which supports its transition to growth [1][5] - The company is focusing on the commercial expansion of its VLN brand, which is expected to drive a shift towards higher-margin proprietary branded products [1][3] Preliminary Financial Results - The company anticipates fourth quarter 2025 net revenues of approximately $3.6 million, down from $4.0 million in the third quarter of 2025 [5] - For the full year 2025, net revenues are expected to be around $17.6 million, a decrease from $24.4 million in 2024 [5] - Total cartons shipped in the fourth quarter 2025 were approximately 0.3 million, compared to 0.5 million in the third quarter of 2025 [5] - The expected gross loss for the fourth quarter 2025 is approximately $0.8 million, an improvement from $1.1 million in the third quarter [5] - The expected operating loss for 2025 is $11.6 million, down from $14.0 million in 2024 [5] - Cash and equivalents at year-end were $7.1 million, with zero long-term debt after extinguishing remaining senior secured debt in 2025 [5] Strategic Focus - The company aims to expand VLN product distribution and consumer awareness while maintaining disciplined cost management and capital allocation [3] - The groundwork for growth is being laid following the fourth quarter launch of VLN and Partner VLN brands [3] - The company remains engaged with the FDA and public health stakeholders to drive health and wellness initiatives for smokers [3]

Core Viewpoint - 22nd Century Group, Inc. is advancing the fight against smoking-related health harms through its VLN reduced nicotine content products, which have been authorized by the FDA as a Modified Risk Tobacco Product [1][4]. Group 1: Product and Market Impact - The VLN reduced nicotine content cigarettes have been shown to lower daily nicotine consumption by 40% over 12 weeks in a study with over 400 participants, indicating their potential to reduce smoking rates and increase quit attempts [2]. - Approximately 28.8 million smokers in the U.S. contribute to over $600 billion in annual healthcare costs related to tobacco harm, highlighting the significant market opportunity for VLN products [2]. - VLN cigarettes contain 95% less nicotine than conventional cigarettes, providing a non-addictive alternative for smokers [3][10]. Group 2: Regulatory and Strategic Developments - The FDA originally authorized VLN combustible cigarettes in December 2021 for a five-year period, with a renewal application filed for December 2026 [3]. - The company is expanding its range of VLN branded products and tobacco plant varieties to offer smokers more low-nicotine alternatives, aligning with the FDA's proposed guidelines for low nicotine [5]. - The renewal process is part of the company's ongoing research and development efforts to advance reduced nicotine content in tobacco and introduce additional VLN products [5]. Group 3: Company Vision and Leadership - The CEO of 22nd Century Group emphasized that the FDA's MRTP authorization for VLN cigarettes represents a forward-thinking approach to reducing smoking-related health harms, focusing on behavioral and social aspects of nicotine addiction [4]. - The company aims to empower smokers to take control of their nicotine consumption through its innovative VLN products, positioning itself as a leader in the tobacco harm reduction movement [8][9].

Core Insights - 22nd Century Group, Inc. is a leader in the tobacco harm reduction movement, focusing on reducing nicotine addiction through innovative products [3][4]. Company Announcement - The CEO, Larry Firestone, will present at the Emerging Growth Virtual Investor Conference on December 10, 2025, at 3:55 PM Eastern Time [1]. Technology and Products - The company has developed proprietary non-GMO reduced nicotine tobacco plants that contain 95% less nicotine than traditional tobacco [4]. - The flagship product, VLN cigarette, is designed to provide traditional smokers with a familiar alternative while significantly reducing nicotine consumption [5]. - VLN cigarettes are the only low nicotine combustible cigarettes authorized by the FDA in the United States [6]. Investor Engagement - Investors can register for the conference online and submit questions in advance for consideration during the event [2]. - An archived webcast will be available for those unable to attend live [2]. Contact Information - Investor relations contact is Matt Kreps, reachable at investorrelations@xxiicentury.com or by phone at 214-597-8200 [8][9].

Core Viewpoint - 22nd Century Group, Inc. is set to host a webcast on November 4, 2025, to discuss its third quarter results for 2025, highlighting its ongoing leadership in tobacco harm reduction and nicotine consumption control [1][2]. Company Overview - 22nd Century Group is a pioneer in the tobacco harm reduction movement, focusing on enabling smokers to manage their nicotine consumption [4]. - The company has developed proprietary non-GMO reduced nicotine tobacco plants that contain 95% less nicotine than traditional tobacco plants, supported by an extensive patent portfolio [5]. Products - The flagship product, VLN cigarette, utilizes low nicotine tobacco, providing traditional smokers with a familiar alternative that helps reduce nicotine consumption by 95% compared to regular cigarettes [6]. - VLN cigarettes are the only low nicotine combustible cigarettes authorized by the FDA in the United States [7]. Webcast Details - The webcast will feature Larry Firestone, CEO, and Dan Otto, CFO, who will review financial results and discuss recent progress and future plans for 2025 [2][3].

Core Viewpoint - The proposed FDA standard for nicotine yield in tobacco products could prevent 4.3 million deaths and save $600 billion annually in economic damages related to smoking [1][3]. Company Position - 22nd Century Group supports the FDA's proposed rule, emphasizing that it could lead to the complete replacement of conventional high-nicotine products with Very Low Nicotine Content (VLNC) products within two years [1][3]. - The company has developed proprietary non-GMO reduced nicotine tobacco plants, which contain 95% less nicotine than traditional tobacco, enabling the production of consumer-acceptable combusted tobacco products [8][9]. Health Impact - The FDA's population health model suggests that adopting the proposed rule could prevent smoking initiation in approximately 48 million youth and young adults and avert 1.8 million tobacco-related deaths by 2060 [3][4]. - Clinical evidence supports that limiting nicotine in combusted tobacco products leads to reduced cigarette consumption, decreased dependence on tobacco, and increased cessation attempts [3][4]. Industry Support - Over 75 health care organizations, including the American Medical Association and the American College of Cardiology, endorse the proposed rule, citing the urgent need for such a standard [4]. - Some organizations argue that the rule should extend to limit nicotine in Heated Tobacco Products (HTPs) as well [4]. Opposition - Major legacy tobacco producers oppose the proposed standard, citing concerns over economic disruption and potential illicit trade [5]. - The company argues that the opposition from these producers contradicts their stated goals of transitioning smokers to less harmful products [5].

Core Insights - 22nd Century Group has settled all claims related to the Grass Valley incident for a one-time payment of $9.5 million, which will be paid by insurers within 45 days [1][2] - The company is now debt-free, marking a transition from survival capital to growth capital, and is positioned to focus on driving profitability by 2026 [2] Company Overview - 22nd Century Group is a leader in the tobacco harm reduction movement, enabling smokers to manage their nicotine consumption [3] - The company has developed proprietary non-GMO reduced nicotine tobacco plants that contain 95% less nicotine than traditional tobacco [4] Product Information - The flagship product, VLN cigarette, is designed for traditional smokers, offering a combustible alternative with 95% less nicotine, proven to help reduce nicotine consumption [5] - VLN cigarette is the only low nicotine combustible cigarette authorized by the FDA in the United States [6]

Core Insights - 22nd Century Group has successfully repaid $3.9 million in senior secured debt, significantly reducing ongoing cash needs and operating costs by eliminating cash interest and amortization expenses [1][2] - The company has eliminated over $20 million in senior secured and subordinated debt since the current CEO joined, positioning itself for growth with a debt-free balance sheet [2] - The completion of the Series A convertible preferred stock offering and debt repayment has resulted in an approximate $9.1 million increase in adjusted pro forma net tangible book value, equating to about $1.05 per share [2] Financial Position - The company’s balance sheet now reflects working capital that supports the purchase of low nicotine leaf crops, enabling the production of more than 1 million cartons of VLN products [1][2] - Plans are in place to deploy a portion of capital to expand the inventory of very low nicotine tobacco leaf in Q4 2025 [2] Product and Technology - 22nd Century Group is pioneering the tobacco harm reduction movement with its proprietary non-GMO reduced nicotine tobacco plants, which contain 95% less nicotine than traditional tobacco [4][5] - The flagship product, VLN cigarettes, provide traditional smokers with a familiar alternative that helps them control their nicotine consumption [5][6] - VLN cigarettes are the only low nicotine combustible cigarettes authorized by the FDA in the United States [6]

Core Insights - 22nd Century Group, Inc. is leading the nicotine harm reduction movement in the tobacco industry, focusing on helping smokers control their nicotine consumption [3][4] - The company will host investor meetings on September 9, 2025, during the HC Wainwright Conference in New York [1][2] Company Overview - 22nd Century Group has developed the VLN cigarette, which contains 95% less nicotine than traditional cigarettes, providing smokers with a familiar alternative to manage their nicotine intake [4][5] - The company utilizes proprietary non-GMO reduced nicotine tobacco blends, supported by patented technologies that regulate nicotine biosynthesis in tobacco plants, ensuring a full flavor experience with lower nicotine levels [5] Product Details - VLN cigarettes are designed to allow consumers to significantly reduce their nicotine consumption while still enjoying a combustible cigarette format [4] - The extensive patent portfolio of 22nd Century Group secures its position as the only provider of low nicotine combustible cigarettes in the United States and key international markets [5]